Log in to save to my catalogue

Cationic Liposomes as Vectors for Nucleic Acid and Hydrophobic Drug Therapeutics

Cationic Liposomes as Vectors for Nucleic Acid and Hydrophobic Drug Therapeutics

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c26ac335137144e4b588566a107610d5

Cationic Liposomes as Vectors for Nucleic Acid and Hydrophobic Drug Therapeutics

About this item

Full title

Cationic Liposomes as Vectors for Nucleic Acid and Hydrophobic Drug Therapeutics

Publisher

Switzerland: MDPI AG

Journal title

Pharmaceutics, 2021-08, Vol.13 (9), p.1365

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Cationic liposomes (CLs) are effective carriers of a variety of therapeutics. Their applications as vectors of nucleic acids (NAs), from long DNA and mRNA to short interfering RNA (siRNA), have been pursued for decades to realize the promise of gene therapy, with approvals of the siRNA therapeutic patisiran and two mRNA vaccines against COVID-19 as...

Alternative Titles

Full title

Cationic Liposomes as Vectors for Nucleic Acid and Hydrophobic Drug Therapeutics

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_c26ac335137144e4b588566a107610d5

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c26ac335137144e4b588566a107610d5

Other Identifiers

ISSN

1999-4923

E-ISSN

1999-4923

DOI

10.3390/pharmaceutics13091365

How to access this item